基本信息
浏览量:92
职业迁徙
个人简介
Roberta Cavalli have a multi-year experience in the design and development of either conventional pharmaceutical formulations or innovative nanotechnology-based drug delivery systems, as well as their in vitro and in vivo characterization. Much research focused the attention on developing novel nanoparticulate formulations to improve the efficacy of the loaded therapeutic molecules. The incorporation of a therapeutic agent within a nanoformulation aims at changing the physico-chemical characteristics of the loaded molecule, modifying the pharmacokinetics and the biodistribution, magnifying the effectiveness and decreasing the side effects. RC developed various types of novel nanocarriers consisting of safe components, generally either polymers or lipids, admitted by the regulatory authorities to assure biocompatibility, biodegradability and low cytotoxicity.
研究兴趣
论文共 247 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 2 (2024): 729
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 4 (2024): 2337
PLANTA MEDICAno. 04 (2024): 267-275
Antiviral Researchpp.105897, (2024)
Francesca Uberti,Francesco Trotta,Roberta Cavalli,Rebecca Galla,Fabrizio Caldera,Sara Ferrari, Simone Mule, Arianna Brovero,Claudio Molinari,Pasquale Pagliaro,Claudia Penna
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 4 (2024): 2189
Microorganismsno. 10 (2023): 2460-2460
引用0浏览0WOS引用
0
0
Planta Medicano. 4 (2023): 267-275
International journal of molecular sciencesno. 12 (2023)
引用0浏览0WOS引用
0
0
Francesca Uberti,Francesco Trotta,Pasquale Pagliaro, Daniel Mihai Bisericaru,Roberta Cavalli,Sara Ferrari,Claudia Penna,Adrián Matencio
International journal of molecular sciencesno. 6 (2023): 5322-5322
Biological and medical physics seriespp.597-629, (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn